COMMUNIQUÉS West-GlobeNewswire

Targovax ASA: Exercise price of options
02/02/2018
With reference to the Stock exchange notification issued 1 February 2018 regarding options to employees: The exercise price of the granted options is NOK 17.17. The exercise price is equal to the volume weighted average [...]
INSYS Therapeutics Addresses New York Attorney General’s Complaint
02/02/2018
PHOENIX, Feb. 01, 2018 (GLOBE NEWSWIRE) -- INSYS Therapeutics, Inc. (NASDAQ: INSY ), a leader in the development, manufacture and commercialization of pharmaceutical cannabinoids and spray technology, today released the [...]
Kane Biotech Provides Additional Information Regarding Engagement of Investor Relations Counsel
02/02/2018
WINNIPEG, Manitoba, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V: KNE ) (OTCQB:KNBIF), (the “Corporation” or “Kane Biotech”) is pleased to announce additional information regarding its engagement of Edison [...]
MedMira Announces AGM Results and Stock Option Grant
02/02/2018
HALIFAX, Nova Scotia, Feb. 01, 2018 (GLOBE NEWSWIRE) -- MedMira Inc. (MedMira) (TSXV:MIR) held its 2018 Annual General Meeting of Shareholders on January 31, 2018 in Halifax, Nova Scotia. Incumbent Directors Mr. Hermes [...]
Revocation of CTO and Reinstatement to Trade
02/02/2018
BROSSARD, Québec, Feb. 01, 2018 (GLOBE NEWSWIRE) -- ZoomMed Inc. (TSX Venture Exchange:ZMD) (“ZoomMed”) is pleased to announce that the TSX Venture Exchange will be issuing a bulletin to reinstate trading in ZoomMed’s [...]
Levée de l’interdiction d’opérations et reprise de la négociation
02/02/2018
BROSSARD, Québec, 01 févr. 2018 (GLOBE NEWSWIRE) -- ZoomMed Inc. (Bourse de croissance TSX:ZMD) (“ZoomMed”) est heureuse d’annoncer que la Bourse de croissance TSX émettra un bulletin visant la reprise de la négociation [...]
MediciNova Announces MN-166 (ibudilast) Demonstrated a 26% Reduction in Confirmed Disability Progression in the SPRINT-MS Phase 2b Trial in Progressive MS: Potential Best-in-Disease Drug
02/02/2018
LA JOLLA, Calif., Feb. 01, 2018 (GLOBE NEWSWIRE) -- MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ: MNOV ) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875 [...]
Marrone Bio Innovations, Inc. Announces Stockholder Approval of Private Placement and Debt Refinance Transactions
01/02/2018
Appoints Two New Board Members; Bob Woods as Chairman and Yogesh Mago Transactions Expected to Close in Early February DAVIS, Calif., Feb. 01, 2018 (GLOBE NEWSWIRE) -- Marrone Bio Innovations, Inc. (“MBI” or the “ [...]
Progenics Pharmaceuticals Announces Presentation of AZEDRA® (iobenguane I 131) Biochemical Tumor Marker Data at the 2018 Endocrine Society (ENDO) Annual Meeting
01/02/2018
NEW YORK, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Progenics Pharmaceuticals, Inc. (Nasdaq: PGNX ), an oncology company developing innovative medicines and imaging analytical tools for targeting and treating cancer, today [...]
Quest Diagnostics Completes Acquisition of MedXM
01/02/2018
Secaucus, NJ, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Quest Diagnostics (NYSE: DGX), the world's leading provider of diagnostic information services, today announced it has completed its previously announced acquisition of [...]
Integra LifeSciences to Host Fourth Quarter 2017 Earnings Results Conference Call on February 27, 2018
01/02/2018
PLAINSBORO, N.J., Feb. 01, 2018 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART ), a leading global medical technology company, will release fourth quarter and full year 2017 financial [...]
Retrophin to Present at the Leerink Partners 7th Annual Global Healthcare Conference
01/02/2018
SAN DIEGO, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Retrophin, Inc. (NASDAQ: RTRX ) today announced that Stephen Aselage, chief executive officer, will present at the Leerink Partners 7th Annual Global Healthcare Conference in [...]
Syneos Health Schedules Fourth Quarter and Year End 2017 Earnings Call for Wednesday, February 28, 2018
01/02/2018
RALEIGH, N.C., Feb. 01, 2018 (GLOBE NEWSWIRE) -- Syneos Health TM (Nasdaq: SYNH ), the only fully integrated biopharmaceutical solutions organization, will release its fourth quarter and year end 2017 financial results [...]
Kane Biotech Retains Edison Advisors as Investor Relations Counsel
01/02/2018
WINNIPEG, Manitoba, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Kane Biotech Inc. (TSX-V: KNE ) (OTCQB:KNBIF), (the “Corporation” or “Kane Biotech”) is pleased to announce that it has retained Edison Advisors (“Edison”), a global [...]
Novartis completes subsequent offering period of the tender offer for Advanced Accelerator Applications S.A.
01/02/2018
Basel, February 1, 2018 - Novartis AG (NYSE: NVS) today announced the completion of the subsequent offering period of the tender offer by its subsidiary, Novartis Groupe France S.A., to purchase all of the outstanding [...]
Adamas Announces Publication of ADS-5102 Phase 2 Clinical Trial Results in Multiple Sclerosis Journal
01/02/2018
EMERYVILLE, Calif., Feb. 01, 2018 (GLOBE NEWSWIRE) -- Adamas Pharmaceuticals, Inc. (Nasdaq: ADMS ) today announced that results of its Phase 2 proof-of-concept clinical trial of ADS-5102 (amantadine) extended release [...]
Advanced Accelerator Applications Announces Completion of Subsequent Offering Period for Novartis Tender Offer
01/02/2018
SAINT-GENIS-POUILLY, France, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Advanced Accelerator Applications S.A. (NASDAQ: AAAP ) (“AAA” or the “Company”), a Novartis company and a leader in nuclear medicine theragnostics, today [...]
Actinium Pharmaceuticals Announces Rights Offering
01/02/2018
NEW YORK, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Actinium Pharmaceuticals, Inc. (NYSE American:ATNM) ("Actinium" or "the Company") announced today that it has filed a preliminary prospectus supplement as a part of a [...]
Prothena to Report Fourth Quarter and Full Year 2017 Financial Results and Host Webcast Conference Call on February 14
01/02/2018
DUBLIN, Ireland, Feb. 01, 2018 (GLOBE NEWSWIRE) -- Prothena Corporation plc (Nasdaq: PRTA ), a late-stage clinical biotechnology company focused on the discovery, development and commercialization of novel protein [...]

Pages